Improved Quality of Life in Patients Treated with Peptide Radionuclides

Peptide receptor radionuclide therapy (PRRT) has recently been established as an important treatment modality for somatostatin receptor (SSTR)-positive tumors. The purpose of this study was to evaluate the clinical response, side-effects as well as the quality of life following (90)Y-DOTA-lanreotide...

Descripción completa

Detalles Bibliográficos
Autores principales: Traub-Weidinger, T, Raderer, M., Uffmann, M., Angelberger, P., Kurtaran, A., Leimer, M., Preitfellner, J., Dudczak, R., Virgolini, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227337/
https://www.ncbi.nlm.nih.gov/pubmed/22144870
http://dx.doi.org/10.4103/1450-1147.89779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227337/
https://www.ncbi.nlm.nih.gov/pubmed/22144870
http://dx.doi.org/10.4103/1450-1147.89779

Ejemplares similares